Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | AHR | P35869 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.63 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.62 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.62 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16231124 | 0.92 | MEN1 (0.73) | MEN1KMT2ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL9196352 | 0.90 | MEN1 (0.67) | MEN1KMT2ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL9192693 | 0.88 | MEN1 (0.68) | MEN1KMT2ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL10647491 | 0.87 | MEN1 (0.62) | MEN1KMT2ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL13788777 | 0.86 | MEN1 (0.78) | MEN1KMT2ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL5475142 | 0.84 | MEN1 (0.66) | MEN1KMT2ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL27626674 | 0.84 | MEN1 (0.58) | MEN1KMT2ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL13788794 | 0.84 | MEN1 (0.66) | MEN1KMT2ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL14178770 | 0.84 | MEN1 (0.63) | MEN1KMT2ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL592866 | 0.84 | MEN1 (0.74) | MEN1KMT2ASMN1; SMN2MAPK1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210088518-A1 | DETECTING MICROBIAL INFECTION IN WOUNDS | SYNOVO GMBH (DE) | 2021-03-25 | — | — | US | disclosed |
| EP-2588144-B1 | DETECTING TARGETS USING MASS TAGS AND MASS SPECTROMETRY | VENTANA MED SYST INC (US) | 2018-05-09 | — | — | EP | disclosed |
| US-9791399-B2 | Derivatization of carbon | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2017-10-17 | — | — | US | disclosed |
| US-9291597-B2 | Detecting targets using mass tags and mass spectrometry | VENTANA MEDICAL SYSTEMS, INC. (US) | 2016-03-22 | — | — | US | disclosed |
| US-20140332412-A1 | DERIVATIZATION OF CARBON | SCHLUMBERGER TECHNOLOGY COPORATION (US) | 2014-11-13 | — | — | US | disclosed |
| US-20130122516-A1 | DETECTING TARGETS USING MASS TAGS AND MASS SPECTROMETRY | VENTANA MEDICAL SYSTEMS, INC. | 2013-05-16 | — | — | US | disclosed |
| WO-2012003478-A2 | DETECTING TARGETS USING MASS TAGS AND MASS SPECTROMETRY | VENTANA MEDICAL SYSTEMS, INC. (US) | 2012-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140332412-A1 | DERIVATIZATION OF CARBON | FTH1, CBR1, SDHB | MEN1 1759/4885KMT2A 961/4885SMN1; SMN2 4435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.